These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 1% sulconazole cream v 2% miconazole cream in the treatment of tinea versicolor. A double-blind, multicenter study. Tanenbaum L; Anderson C; Rosenberg MJ; Akers W Arch Dermatol; 1984 Feb; 120(2):216-9. PubMed ID: 6364994 [TBL] [Abstract][Full Text] [Related]
3. Can pityriasis versicolor be treated with 2% ketoconazole foam? Cantrell WC; Elewksi BE J Drugs Dermatol; 2014 Jul; 13(7):855-9. PubMed ID: 25007370 [TBL] [Abstract][Full Text] [Related]
4. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor. Köse O; Bülent Taştan H; Riza Gür A; Kurumlu Z J Dermatolog Treat; 2002 Jun; 13(2):77-9. PubMed ID: 12060506 [TBL] [Abstract][Full Text] [Related]
5. Single-dose oral fluconazole versus topical clotrimazole in patients with pityriasis versicolor: A double-blind randomized controlled trial. Dehghan M; Akbari N; Alborzi N; Sadani S; Keshtkar AA J Dermatol; 2010 Aug; 37(8):699-702. PubMed ID: 20649710 [TBL] [Abstract][Full Text] [Related]
6. Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%. Clin Ther; 1985; 7(5):574-83. PubMed ID: 2865009 [TBL] [Abstract][Full Text] [Related]
7. The effect of topical retinoic acid (Airol) in the treatment of tinea versicolor. Handojo I; Subagjo B; Hadi S Southeast Asian J Trop Med Public Health; 1977 Mar; 8(1):93-8. PubMed ID: 888002 [TBL] [Abstract][Full Text] [Related]
8. Pityriasis versicolor: clinical experience with Lamisil cream and Lamisil DermGel. Faergemann J; Hersle K; Nordin P Dermatology; 1997; 194 Suppl 1():19-21. PubMed ID: 9154396 [TBL] [Abstract][Full Text] [Related]
9. Fluconazole versus ketoconazole in the treatment of tinea versicolor. Farschian M; Yaghoobi R; Samadi K J Dermatolog Treat; 2002 Jun; 13(2):73-6. PubMed ID: 12060505 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of Pityriasis versicolor. Nasarre J; Umbert P; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA Arzneimittelforschung; 1992 May; 42(5A):764-7. PubMed ID: 1627203 [TBL] [Abstract][Full Text] [Related]
11. A new treatment for tinea versicolor using econazole nitrate 1.0 percent cream once a day. Vicik GJ; Mendiones M; Quinones CA; Thorne EG Cutis; 1984 Jun; 33(6):570-1. PubMed ID: 6744948 [TBL] [Abstract][Full Text] [Related]
12. [A double-blind placebo-controlled study of a 2 percent foaming lotion of ketoconazole in a single application in the treatment of pityriasis versicolor]. Rekacewicz I; Guillaume JC; Benkhraba F; Archimbaud A; Baspeyras M; Boitier F; Bussière M; Coin A; Di Crezenzo MC; Duval J Ann Dermatol Venereol; 1990; 117(10):709-11. PubMed ID: 2073061 [TBL] [Abstract][Full Text] [Related]
13. Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial. Rigopoulos D; Gregoriou S; Kontochristopoulos G; Ifantides A; Katsambas A Mycoses; 2007 May; 50(3):193-5. PubMed ID: 17472615 [TBL] [Abstract][Full Text] [Related]
14. Clinical experience with fenticonazole 2% formulation in the treatment of dermatomycoses and pityriasis versicolor. Aste N; Pau M; Zucca M; Biggio P Int J Clin Pharmacol Res; 1987; 7(6):503-6. PubMed ID: 3440641 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050 [TBL] [Abstract][Full Text] [Related]
16. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent. Jegasothy BV; Pakes GE Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718 [TBL] [Abstract][Full Text] [Related]
17. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis. Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179 [TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized, placebo-controlled, dose-finding study of oral pramiconazole in the treatment of pityriasis versicolor. Faergemann J; Todd G; Pather S; Vawda ZF; Gillies JD; Walford T; Barranco C; Quiring JN; Briones M J Am Acad Dermatol; 2009 Dec; 61(6):971-6. PubMed ID: 19828211 [TBL] [Abstract][Full Text] [Related]
19. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study. Faghihi G; Iraji F; Shahingohar A; Saidat A J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511 [TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study. Di Fonzo EM; Martini P; Mazzatenta C; Lotti L; Alvino S Mycoses; 2008 Nov; 51(6):532-5. PubMed ID: 18422916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]